UnitedHealth Group Reports First Quarter Results
- First Quarter Revenues of $55.2 Billion Grew 13.3% Year-Over-Year
- Earnings from Operations Increased 18.8% to $4.1 Billion, with Every Business Reporting
Double-Digit Percentage Earnings Growth
- Cash Flows from Operations were $8.4 Billion in First Quarter; Adjusted Cash Flows from
Operations were $3.2 Billion
- First Quarter Net Earnings of $2.87 Per Share Grew 28.7% Year-Over-Year
- First Quarter Adjusted Net Earnings of $3.04 Per Share Grew 28.3%
Year-Over-Year
UnitedHealth Group (NYSE: UNH) reported first quarter results, led by continued strong, broad-based performance across the
enterprise.
“Through the intense focus our 285,000 colleagues bring to helping people live healthier lives and helping make the health
system work better for everyone, we have grown to serve more people in more ways than ever, including through innovative uses of
advanced technologies, data analytics, and modern clinical approaches that improve quality, lower cost and advance consumer and
care provider satisfaction,” said David S. Wichmann, chief executive officer of UnitedHealth Group.
Based on first quarter results and the business outlook for the balance of the year, UnitedHealth Group has
increased its outlook for 2018 net earnings to a range of $11.70 to $11.95 per share and adjusted net earnings of $12.40 to $12.65
per share.
UnitedHealth Group
| |
| Quarterly Financial Performance |
|
|
Three Months Ended
|
|
|
March 31, |
|
March 31, |
|
December 31, |
|
|
2018
|
|
2017
|
|
2017
|
| Revenues |
|
$55.2 billion |
|
$48.7 billion |
|
$52.1 billion |
| Earnings From Operations |
|
$4.1 billion |
|
$3.4 billion |
|
$4.0 billion |
| Net Margin |
|
5.1% |
|
4.5% |
|
6.9%1
|
- UnitedHealth Group’s first quarter 2018 revenues grew 13.3 percent or $6.5 billion year-over-year to
$55.2 billion.
- First quarter earnings from operations grew $640 million or 18.8 percent year-over-year to $4.1
billion. Adjusted net earnings of $3.04 per share grew 28.3 percent.
- Adjusted cash flows from operations of $3.2 billion were 1.1x net income in first quarter 2018,
compared to $2.0 billion and 0.9x net income in first quarter 2017.
- The revenue effect from the return of the health insurance tax in first quarter 2018 was the primary
driver of the 100 basis point year-over-year decrease in the consolidated medical care ratio to 81.4 percent. Medical cost
reserves developed favorably by $290 million in first quarter 2018.
- The operating cost ratio of 15.4 percent in the first quarter of 2018 increased 100 basis points
year-over-year in response to the return of the health insurance tax.
- The first quarter 2018 income tax rate of 21.5 percent reflected the reduced federal statutory rate
and seasonally higher stock-based compensation activity, partially offset by the return of the nondeductible health insurance
tax.
- First quarter 2018 days claims payable of 49 days were essentially flat sequentially and
year-over-year; first quarter days sales outstanding rose two days sequentially and one day year-over-year to 19 days, due to the
addition of Empresas Banmédica and growth in government-based offerings.
- UnitedHealth Group repurchased 11.6 million shares for $2.65 billion in the first quarter and paid
$722 million in dividends to shareholders, an increase of 21.1 percent over first quarter 2017.
- Annualized return on shareholders’ equity increased 210 basis points year-over-year to 23.8 percent
in the first quarter. Debt to total capital of 41.6 percent at March 31, 2018 decreased 190 basis points year-over-year, while
increasing 270 basis points sequentially due principally to the Empresas Banmédica merger.
____________________
1 Fourth quarter 2017 included a $1.2 billion favorable non-cash revaluation of the Company’s U.S. net deferred tax
liability, increasing net margin by 230 basis points in that quarter.
UnitedHealthcare
UnitedHealthcare provides global health care benefits, serving individuals and employers, and Medicare and
Medicaid beneficiaries.
| |
| Quarterly Financial Performance |
|
|
Three Months Ended
|
|
|
March 31, |
|
March 31, |
|
December 31, |
|
|
2018
|
|
2017
|
|
2017
|
| Revenues |
|
$45.5 billion |
|
$40.1 billion |
|
$41.6 billion |
| Earnings From Operations |
|
$2.4 billion |
|
$2.1 billion |
|
$1.8 billion |
| Operating Margin |
|
5.3% |
|
5.3% |
|
4.2% |
- UnitedHealthcare grew to serve 2.2 million more consumers2 in the first quarter of 2018,
helping grow revenues by $5.3 billion or 13.3 percent year-over-year to $45.5 billion. First quarter 2018 earnings from
operations of $2.4 billion grew 12.5 percent.
- UnitedHealthcare Employer & Individual first quarter 2018
revenues of $13.4 billion increased $675 million year-over-year, due to growth in people served over the past 12 months,
increases in rates to cover expected medical cost trends and the resumption of the health insurance tax. As expected,
UnitedHealthcare Employer & Individual served 195,000 fewer people in commercial group plans in the quarter, reflecting
employers shifting their retirees from self-funded offerings to group Medicare Advantage plans, and lower retention due to
pricing actions to cover the full cost of the health insurance tax.
- UnitedHealthcare Medicare & Retirement grew revenues by $2.4
billion or 14.3 percent year-over-year to $18.9 billion in the first quarter of 2018. The business served 375,000 more
seniors in the quarter, including 330,000 in Medicare Advantage through individual products and employer-sponsored group
retiree plans. The number of people served through Medicare Advantage grew 10.6 percent year-over-year.
- In first quarter 2018, UnitedHealthcare Community & State
revenues of $10.7 billion grew $1.7 billion or 19.2 percent year-over-year, reflecting strong 12-month membership growth and
an increasing mix of individuals with higher clinical needs. First quarter membership was consistent with year end 2017, as
strong growth serving people in continuing markets offset the Delaware market withdrawal.
- UnitedHealthcare Global served 6.1 million people at March 31, 2018,
having broadened its platform to serve people in Chile, Colombia and Peru through a merger with Empresas Banmédica, a leading
health plan and care delivery organization serving more than 2 million people with health care benefits. Global revenues of
$2.45 billion grew 29.2 percent year-over-year.
____________________
2 Reflects net consumer growth excluding the TRICARE military health program, which concluded in 2017.
Optum
Optum is a health services business serving the global health care marketplace, including payers, care
providers, employers, governments, life sciences companies and consumers. Using market-leading information, data analytics,
technology and clinical insights, Optum’s people help improve overall health system performance: optimizing care quality, reducing
health care costs and improving the consumer experience and health system performance.
| |
| Quarterly Financial Performance |
|
|
Three Months Ended
|
|
|
March 31, |
|
March 31, |
|
December 31, |
|
|
2018
|
|
2017
|
|
2017
|
| Revenues |
|
$23.6 billion |
|
$21.2 billion |
|
$24.4 billion |
| Earnings From Operations |
|
$1.7 billion |
|
$1.3 billion |
|
$2.2 billion |
| Operating Margin |
|
7.0% |
|
6.0% |
|
9.1% |
- In the first quarter of 2018, Optum revenues grew year-over-year by $2.4 billion or 11.1 percent to
$23.6 billion. Optum’s operating margin of 7 percent increased 100 basis points year-over-year in total, with performance
improvements at each business. First quarter earnings from operations grew $374 million or 29.2 percent year-over-year to $1.7
billion, with double-digit percentage increases for every business segment.
- OptumHealth revenues of $5.8 billion grew $1 billion or 21.7 percent
year-over-year, driven by growth in care delivery and behavioral, digital consumer engagement and health financial services.
OptumHealth served 91 million people at quarter end, having grown by 9 million people3 or 11 percent over the past
year.
- OptumInsight revenues grew 12.3 percent to $2.1 billion in first
quarter 2018, driven by growth and expansion in payer technology and services and care provider advisory services.
OptumInsight’s contract backlog of $15.2 billion grew year-over-year by $2.1 billion or 16 percent.
- OptumRx first quarter 2018 revenues grew 7.8 percent year-over-year
to $16.1 billion. OptumRx fulfilled 332 million adjusted scripts in first quarter 2018, growing 3.1 percent over the prior
year, with favorable mix in specialty pharmacy and home delivery services.
____________________
3 Reflects net consumer growth excluding the TRICARE military health program, which concluded in 2017.
About UnitedHealth Group
UnitedHealth Group (NYSE: UNH) is a diversified health and well-being company dedicated to helping people live healthier lives
and helping make the health system work better for everyone. UnitedHealth Group offers a broad spectrum of products and services
through two distinct platforms: UnitedHealthcare, which provides health care coverage and benefits services; and Optum, which
provides information and technology-enabled health services. For more information, visit UnitedHealth Group at www.unitedhealthgroup.com or follow @UnitedHealthGrp on Twitter.
Earnings Conference Call
As previously announced, UnitedHealth Group will discuss the Company’s results, strategy and future outlook on a conference call
with investors at 8:45 a.m. Eastern Time today. UnitedHealth Group will host a live webcast of this conference call from the
Investors page of the Company’s website (www.unitedhealthgroup.com). Following the call, a webcast replay will be available on the same site through May
1, 2018. The conference call replay can also be accessed by dialing 1-800-753-8878. This earnings release and the Form 8-K dated
April 17, 2018 can also be accessed from the Investors page of the Company’s website.
Non-GAAP Financial Information
This news release presents non-GAAP financial information provided as a complement to the results provided in accordance with
accounting principles generally accepted in the United States of America (“GAAP”). A reconciliation of the non-GAAP financial
information to the most directly comparable GAAP financial measure is provided in the accompanying tables found at the end of this
release.
Forward-Looking Statements
The statements, estimates, projections, guidance or outlook contained in this document include “forward-looking” statements
within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA). These statements are intended to take advantage
of the “safe harbor” provisions of the PSLRA. Generally the words “believe,” “expect,” “intend,” “estimate,” “anticipate,”
“forecast,” “outlook,” “plan,” “project,” “should” and similar expressions identify forward-looking statements, which generally are
not historical in nature. These statements may contain information about financial prospects, economic conditions and trends and
involve risks and uncertainties. We caution that actual results could differ materially from those that management expects,
depending on the outcome of certain factors.
Some factors that could cause actual results to differ materially from results discussed or implied in the forward-looking
statements include: our ability to effectively estimate, price for and manage our medical costs, including the impact of any new
coverage requirements; new laws or regulations, or changes in existing laws or regulations, or their enforcement or application,
including increases in medical, administrative, technology or other costs or decreases in enrollment resulting from U.S., Brazilian
and other jurisdictions’ regulations affecting the health care industry; the outcome of the Department of Justice’s legal actions
relating to risk adjustment submission matters; our ability to maintain and achieve improvement in CMS star ratings and other
quality scores that impact revenue; reductions in revenue or delays to cash flows received under Medicare, Medicaid and other
government programs, including the effects of a prolonged U.S. government shutdown or debt ceiling constraints; changes in
Medicare, including changes in payment methodology, the CMS star ratings program or the application of risk adjustment data
validation audits; cyber-attacks or other privacy or data security incidents; failure to comply with privacy and data security
regulations; regulatory and other risks and uncertainties of the pharmacy benefits management industry; competitive pressures,
which could affect our ability to maintain or increase our market share; changes in or challenges to our public sector contract
awards; our ability to execute contracts on competitive terms with physicians, hospitals and other service providers; failure to
achieve targeted operating cost productivity improvements, including savings resulting from technology enhancement and
administrative modernization; increases in costs and other liabilities associated with increased litigation, government
investigations, audits or reviews; failure to manage successfully our strategic alliances or complete or receive anticipated
benefits of acquisitions and other strategic transactions; fluctuations in foreign currency exchange rates on our reported
shareholders’ equity and results of operations; downgrades in our credit ratings; the performance of our investment portfolio;
impairment of the value of our goodwill and intangible assets if estimated future results do not adequately support goodwill and
intangible assets recorded for our existing businesses or the businesses that we acquire; failure to maintain effective and
efficient information systems or if our technology products do not operate as intended; and our ability to obtain sufficient funds
from our regulated subsidiaries or the debt or capital markets to fund our obligations, to maintain our debt to total capital ratio
at targeted levels, to maintain our quarterly dividend payment cycle or to continue repurchasing shares of our common stock.
This list of important factors is not intended to be exhaustive. We discuss certain of these matters more fully, as well as
certain risk factors that may affect our business operations, financial condition and results of operations, in our filings with
the Securities and Exchange Commission, including our annual reports on Form 10-K, quarterly reports on Form 10-Q and current
reports on Form 8-K. Any or all forward-looking statements we make may turn out to be wrong, and can be affected by inaccurate
assumptions we might make or by known or unknown risks and uncertainties. By their nature, forward-looking statements are not
guarantees of future performance or results and are subject to risks, uncertainties and assumptions that are difficult to predict
or quantify. Actual future results may vary materially from expectations expressed or implied in this document or any of our prior
communications. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made.
We do not undertake to update or revise any forward-looking statements, except as required by applicable securities laws.
| |
| UNITEDHEALTH GROUP |
| |
| Earnings Release Schedules and Supplementary Information |
| Quarter Ended March 31, 2018 |
| |
| - Condensed Consolidated Statements of Operations |
| - Condensed Consolidated Balance Sheets |
| - Condensed Consolidated Statements of Cash Flows |
| - Supplemental Financial Information - Businesses |
| - Supplemental Financial Information - Business Metrics |
| - Reconciliation of Non-GAAP Financial Measures |
| |
UNITEDHEALTH GROUP
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in millions, except per share data)
(unaudited) |
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
2018 |
|
2017 |
| Revenues |
|
|
|
|
| Premiums |
|
$ |
44,084 |
|
|
$ |
38,938 |
|
| Products |
|
|
6,702 |
|
|
|
6,129 |
|
| Services |
|
|
4,104 |
|
|
|
3,434 |
|
| Investment and other income |
|
|
298 |
|
|
|
222 |
|
| Total revenues |
|
|
55,188 |
|
|
|
48,723 |
|
| Operating costs |
|
|
|
|
| Medical costs |
|
|
35,863 |
|
|
|
32,079 |
|
| Operating costs |
|
|
8,506 |
|
|
|
7,022 |
|
| Cost of products sold |
|
|
6,184 |
|
|
|
5,676 |
|
| Depreciation and amortization |
|
|
582 |
|
|
|
533 |
|
| Total operating costs |
|
|
51,135 |
|
|
|
45,310 |
|
| Earnings from operations |
|
|
4,053 |
|
|
|
3,413 |
|
| Interest expense |
|
|
(329 |
) |
|
|
(283 |
) |
| Earnings before income taxes |
|
|
3,724 |
|
|
|
3,130 |
|
| Provision for income taxes |
|
|
(800 |
) |
|
|
(939 |
) |
| Net earnings |
|
|
2,924 |
|
|
|
2,191 |
|
| Earnings attributable to noncontrolling interests |
|
|
(88 |
) |
|
|
(19 |
) |
|
Net earnings attributable to UnitedHealth Group common shareholders
|
|
$ |
2,836 |
|
|
$ |
2,172 |
|
|
Diluted earnings per share attributable to UnitedHealth Group common shareholders
|
|
$ |
2.87 |
|
|
$ |
2.23 |
|
|
Adjusted earnings per share attributable to UnitedHealth Group common shareholders (a)
|
|
$ |
3.04 |
|
|
$ |
2.37 |
|
| Diluted weighted-average common shares outstanding |
|
|
987 |
|
|
|
975 |
|
|
|
|
|
|
|
(a) See page 6 for a reconciliation of the non-GAAP measure
|
|
|
UNITEDHEALTH GROUP
CONDENSED CONSOLIDATED BALANCE SHEETS
(in millions)
(unaudited) |
|
|
|
|
|
|
|
March 31,
2018 |
|
December 31,
2017 |
| Assets |
|
|
|
|
| Cash and short-term investments |
|
$ |
22,041 |
|
$ |
15,490 |
| Accounts receivable, net |
|
|
11,512 |
|
|
9,568 |
| Other current assets |
|
|
14,800 |
|
|
12,026 |
| Total current assets |
|
|
48,353 |
|
|
37,084 |
| Long-term investments |
|
|
29,441 |
|
|
28,341 |
| Other long-term assets |
|
|
77,775 |
|
|
73,633 |
| Total assets |
|
$ |
155,569 |
|
$ |
139,058 |
|
|
|
|
|
| Liabilities, redeemable noncontrolling interests and equity |
|
|
|
|
| Medical costs payable |
|
$ |
19,589 |
|
$ |
17,871 |
| Commercial paper and current maturities of long-term debt |
|
|
7,379 |
|
|
2,857 |
| Other current liabilities |
|
|
40,699 |
|
|
29,735 |
| Total current liabilities |
|
|
67,667 |
|
|
50,463 |
| Long-term debt, less current maturities |
|
|
28,206 |
|
|
28,835 |
| Other long-term liabilities |
|
|
7,770 |
|
|
7,738 |
| Redeemable noncontrolling interests |
|
|
1,890 |
|
|
2,189 |
| Equity |
|
|
50,036 |
|
|
49,833 |
| Total liabilities, redeemable noncontrolling interests and equity |
|
$ |
155,569 |
|
$ |
139,058 |
| |
UNITEDHEALTH GROUP
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in millions)
(unaudited) |
|
|
|
|
|
|
|
Three Months Ended
March 31,
|
|
|
2018 |
|
2017 |
| Operating Activities |
|
|
|
|
| Net earnings |
|
$ |
2,924 |
|
|
$ |
2,191 |
|
| Noncash items: |
|
|
|
|
| Depreciation and amortization |
|
|
582 |
|
|
|
533 |
|
| Deferred income taxes and other |
|
|
(47 |
) |
|
|
(46 |
) |
| Share-based compensation |
|
|
208 |
|
|
|
196 |
|
| Net changes in operating assets and liabilities |
|
|
4,702 |
|
|
|
3,582 |
|
| Cash flows from operating activities |
|
|
8,369 |
|
|
|
6,456 |
|
|
|
|
|
|
| Investing Activities |
|
|
|
|
| Purchases of investments, net of sales and maturities |
|
|
(1,385 |
) |
|
|
(1,339 |
) |
| Purchases of property, equipment and capitalized software |
|
|
(477 |
) |
|
|
(507 |
) |
| Cash paid for acquisitions, net |
|
|
(2,583 |
) |
|
|
(468 |
) |
| Other, net |
|
|
(72 |
) |
|
|
25 |
|
| Cash flows used for investing activities |
|
|
(4,517 |
) |
|
|
(2,289 |
) |
|
|
|
|
|
| Financing Activities |
|
|
|
|
| Common share repurchases |
|
|
(2,650 |
) |
|
|
(682 |
) |
| Dividends paid |
|
|
(722 |
) |
|
|
(596 |
) |
| Net change in commercial paper and long-term debt |
|
|
3,159 |
|
|
|
(189 |
) |
| Other, net |
|
|
2,635 |
|
|
|
2,992 |
|
| Cash flows from financing activities |
|
|
2,422 |
|
|
|
1,525 |
|
| Effect of exchange rate changes on cash and cash equivalents |
|
|
(12 |
) |
|
|
20 |
|
| Increase in cash and cash equivalents |
|
|
6,262 |
|
|
|
5,712 |
|
| Cash and cash equivalents, beginning of period |
|
|
11,981 |
|
|
|
10,430 |
|
| Cash and cash equivalents, end of period |
|
$ |
18,243 |
|
|
$ |
16,142 |
|
|
|
|
|
|
| Supplemental Schedule of Noncash Investing Activities |
|
|
|
|
| Common stock issued for acquisition |
|
$ |
- |
|
|
$ |
1,860 |
|
| |
UNITEDHEALTH GROUP
SUPPLEMENTAL FINANCIAL INFORMATION - BUSINESSES
(in millions, except percentages)
(unaudited) |
|
|
|
|
|
|
|
|
|
Three Months Ended
March 31,
|
|
|
|
2018 |
|
2017 |
| Revenues |
|
|
|
|
| UnitedHealthcare |
|
$ |
45,459 |
|
|
$ |
40,136 |
|
| Optum |
|
|
23,601 |
|
|
|
21,237 |
|
| Eliminations |
|
|
(13,872 |
) |
|
|
(12,650 |
) |
|
Total consolidated revenues |
|
$ |
55,188 |
|
|
$ |
48,723 |
|
|
|
|
|
|
|
| Earnings from Operations |
|
|
|
|
| UnitedHealthcare |
|
$ |
2,400 |
|
|
$ |
2,134 |
|
| Optum (a) |
|
|
1,653 |
|
|
|
1,279 |
|
|
Total consolidated earnings from operations |
|
$ |
4,053 |
|
|
$ |
3,413 |
|
|
|
|
|
|
|
| Operating Margin |
|
|
|
|
| UnitedHealthcare |
|
|
5.3 |
% |
|
|
5.3 |
% |
| Optum |
|
|
7.0 |
% |
|
|
6.0 |
% |
|
Consolidated operating margin |
|
|
7.3 |
% |
|
|
7.0 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
| Revenues |
|
|
|
|
| UnitedHealthcare Employer & Individual |
|
$ |
13,414 |
|
|
$ |
12,739 |
|
| UnitedHealthcare Medicare & Retirement |
|
|
18,925 |
|
|
|
16,552 |
|
| UnitedHealthcare Community & State |
|
|
10,671 |
|
|
|
8,949 |
|
| UnitedHealthcare Global |
|
|
2,449 |
|
|
|
1,896 |
|
|
|
|
|
|
|
| OptumHealth |
|
$ |
5,759 |
|
|
$ |
4,733 |
|
| OptumInsight |
|
|
2,069 |
|
|
|
1,843 |
|
| OptumRx |
|
|
16,106 |
|
|
|
14,947 |
|
| Optum eliminations |
|
|
(333 |
) |
|
|
(286 |
) |
|
|
|
|
|
|
| (a) |
Earnings from operations for Optum for the three months ended March 31,
2018 and 2017 included $488 and $332 for OptumHealth; $395 and $294 for OptumInsight; and $770 and $653 for OptumRx,
respectively. |
| |
UNITEDHEALTH GROUP
SUPPLEMENTAL FINANCIAL INFORMATION - BUSINESS METRICS |
|
|
|
|
|
|
|
UNITEDHEALTHCARE CUSTOMER PROFILE
(in thousands) |
|
|
|
|
|
|
|
| People Served |
|
March 31,
2018
|
|
December 31,
2017
|
|
March 31,
2017
|
|
|
|
|
|
|
|
| Commercial group: |
|
|
|
|
|
|
| Risk-based |
|
|
7,860 |
|
|
7,935 |
|
|
7,695 |
| Fee-based |
|
|
18,475 |
|
|
18,595 |
|
|
19,155 |
| Total commercial group |
|
|
26,335 |
|
|
26,530 |
|
|
26,850 |
| Individual |
|
|
475 |
|
|
485 |
|
|
585 |
| Total Commercial (a) |
|
|
26,810 |
|
|
27,015 |
|
|
27,435 |
| Medicare Advantage |
|
|
4,760 |
|
|
4,430 |
|
|
4,305 |
| Medicaid |
|
|
6,695 |
|
|
6,705 |
|
|
6,200 |
| Medicare Supplement (Standardized) |
|
|
4,490 |
|
|
4,445 |
|
|
4,350 |
| Total Public and Senior |
|
|
15,945 |
|
|
15,580 |
|
|
14,855 |
| Total UnitedHealthcare - Domestic Medical |
|
|
42,755 |
|
|
42,595 |
|
|
42,290 |
| International |
|
|
6,095 |
|
|
4,080 |
|
|
4,165 |
| Total UnitedHealthcare - Medical |
|
|
48,850 |
|
|
46,675 |
|
|
46,455 |
|
|
|
|
|
|
|
| Supplemental Data |
|
|
|
|
|
|
| Medicare Part D stand-alone |
|
|
4,770 |
|
|
4,940 |
|
|
4,955 |
|
|
|
|
|
|
|
| OPTUM PERFORMANCE METRICS |
|
|
|
|
|
|
|
|
|
March 31,
2018
|
|
December 31,
2017
|
|
March 31,
2017
|
|
|
|
|
|
|
|
| OptumHealth Consumers Served (in millions) (a) |
|
|
91 |
|
|
88 |
|
|
82 |
| OptumInsight Contract Backlog (in billions) |
|
$ |
15.2 |
|
$ |
15.0 |
|
$ |
13.1 |
| OptumRx Quarterly Adjusted Scripts (in millions) |
|
|
332 |
|
|
333 |
|
|
322 |
|
|
|
|
|
|
|
| (a) Excludes TRICARE of 2.9 million at December 31, 2017 and March 31,
2017. |
| |
| Note: UnitedHealth Group served 139 million unique individuals across
all businesses at March 31, 2018. |
| |
| UNITEDHEALTH GROUP |
| |
| Reconciliation of Non-GAAP Financial Measures |
| |
| - Adjusted Net Earnings per Share |
| |
| - Adjusted Cash Flows from Operations |
| |
| Use of Non-GAAP Financial Measures |
|
Adjusted net earnings per share and adjusted cash flows from operations are non-GAAP financial measures. Non-GAAP financial
measures should be considered in addition to, but not as a substitute for, or superior to, financial measures prepared in
accordance with GAAP.
Adjusted net earnings per share excludes from the relevant GAAP metric, as applicable, intangible
amortization and other items, if any, that do not relate to the Company's underlying business performance. Management
believes that the use of adjusted net earnings per share provides investors and management useful information about the
earnings impact of acquisition-related intangible asset amortization. Management believes the exclusion of these items
provides a more useful comparison of the Company's underlying business performance from period to period.
Management believes that the use of adjusted cash flows from operations provides investors and
management with useful information to compare our cash flows from operations for the current period to that of other periods,
when the Company does not receive its monthly payment from the Centers for Medicare and Medicaid Services (CMS) in the
applicable quarter. CMS generally remits their monthly payments on the first calendar day of the applicable month. However,
if the first calendar day of the month falls on a weekend or a holiday, CMS has typically paid the Company on the last
business day of the preceding calendar month. As such, quarterly operating cash flows determined in accordance with GAAP may
occasionally include CMS premium payments for two months or four months. Adjusted cash flows from operating activities
presents operating cash flows assuming all CMS payments were received on the first calendar day of the applicable month.
|
| |
UNITEDHEALTH GROUP
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
(in millions, except per share data)
(unaudited) |
|
|
|
|
|
|
|
|
| ADJUSTED NET EARNINGS PER SHARE |
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
Projected
Year Ended
December 31,
|
|
|
|
2018 |
|
2017 |
|
2018 |
| GAAP net earnings attributable to UnitedHealth Group common shareholders |
|
|
$ |
2,836 |
|
|
$ |
2,172 |
|
|
$11,525 to $11,775
|
| Intangible amortization |
|
|
|
220 |
|
|
|
219 |
|
|
~885 |
| Tax effect of intangible amortization |
|
|
|
(55 |
) |
|
|
(82 |
) |
|
~(220) |
| Adjusted net earnings attributable to UnitedHealth Group common
shareholders |
|
|
$ |
3,001 |
|
|
$ |
2,309 |
|
|
$12,200 to $12,450 |
|
|
|
|
|
|
|
|
| GAAP diluted earnings per share |
|
|
$ |
2.87 |
|
|
$ |
2.23 |
|
|
$11.70 to $11.95 |
| Intangible amortization per share |
|
|
|
0.22 |
|
|
|
0.22 |
|
|
~0.90 |
| Tax effect per share of intangible amortization |
|
|
|
(0.05 |
) |
|
|
(0.08 |
) |
|
~(0.20) |
| Adjusted diluted earnings per share |
|
|
$ |
3.04 |
|
|
$ |
2.37 |
|
|
~$12.40 to $12.65 |
|
|
|
|
|
|
|
|
| ADJUSTED CASH FLOWS FROM OPERATIONS |
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
|
|
|
2018 |
|
2017 |
|
|
| GAAP cash flows from operations |
|
|
$ |
8,369 |
|
|
$ |
6,456 |
|
|
|
| Add: April CMS premium payments received in March |
|
|
|
(5,144 |
) |
|
|
(4,442 |
) |
|
|
| Adjusted cash flows from operations |
|
|
$ |
3,225 |
|
|
$ |
2,014 |
|
|
|
Click here to subscribe to Mobile Alerts for UnitedHealth Group.
UnitedHealth Group
Investors:
Brett Manderfeld, 952-936-7216
Vice President
or
John S. Penshorn, 952-936-7214
Senior Vice President
or
Media:
Tyler Mason, 424-333-6122
Vice President
View source version on businesswire.com: https://www.businesswire.com/news/home/20180417005655/en/